Clinical Trial Update: Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation [NA]

View source ↗

Summary

This clinical trial evaluated deferoxamine to manage iron overload before allogeneic stem cell transplantation in patients with acute myeloid leukemia, acute ly…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Deferoxamine (deferoxamine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | NA | Status: TERMINATED | Results posted: 2013-04-09